Recent News
The Chase Group Secures VP, Head of Regulatory Affairs for Checkmate Pharmaceuticals
The Chase Group is pleased to announce the successful recruitment of Elvis Osei Tutu, PharmD, as the Vice President, Head of Regulatory Affairs at Checkmate… Continue Reading →
The Chase Group Secures Teng Jin Ong for Genmab
Amid an era of rapid growth, Genmab retained The Chase Group to secure a new clinical development medical executive as they work to pioneer the… Continue Reading →Ventria Bioscience Cuts to The Chase!
Ventria Bioscience is embarking on a path of accelerated growth as they work to double their capacity for multiple products this year. As part of… Continue Reading →Genmab Continues Partnership with The Chase Group as their Drug Safety Leadership Team Grows
Over the past three years, Genmab has retained The Chase Group to execute four Director, Drug Safety and Pharmacovigilance (PV) physician searches that all concluded… Continue Reading →
Growth is on the Horizon as Biologics Consulting continues Partnership with The Chase Group to Expand Leadership Team
The Chase Group is pleased to announce their continued partnership with Biologics Consulting after being retained to execute a search for a Business Development Lead…. Continue Reading →
Ferrer Partners with The Chase Group to Identify US Business Development Leader
The Chase Group’s successful partnership with Alexza Pharmaceuticals has extended to include their parent company, Ferrer. A privately held company based in Barcelona, Spain, Ferrer… Continue Reading →
The Chase Group Secures Clinical Operations Leadership for Alexza Pharmaceuticals
The Chase Group, committed to executive recruitment in life sciences, is pleased to announce the completion of another search for Alexza Pharmaceuticals, successfully securing Mike… Continue Reading →
Arcturus Therapeutics Secures Head of Drug Safety Through Continued Partnership with The Chase Group
The Chase Group’s track record for success continues with another executive placement secured for Arcturus Therapeutics. Entering a new stage in clinical development, Arcturus retained… Continue Reading →